Competitive problems in the drug industry: hearings before Subcommittee on Monopoly and Anticompetitive Activities of the Select Committee on Small Business, United States Senate, Ninety-first Congress, first session ... |
From inside the book
Results 1-5 of 100
Page 11637
... reimbursement under various Government programs . We are partic- ularly interested in finding ways in which competition can be pro- moted for the benefit of small business and the public and the cost of drugs under medicare and medicaid ...
... reimbursement under various Government programs . We are partic- ularly interested in finding ways in which competition can be pro- moted for the benefit of small business and the public and the cost of drugs under medicare and medicaid ...
Page 11640
... reimbursement without sacrificing the quality of health care . The Maximum Allowable Cost program - or MAC - is well along toward its implementation . I would like to mention just a few things as background . In 1970 , the Department ...
... reimbursement without sacrificing the quality of health care . The Maximum Allowable Cost program - or MAC - is well along toward its implementation . I would like to mention just a few things as background . In 1970 , the Department ...
Page 11641
... reimbursement systems . do not accurately reflect the two components that make up the retail price of a drug - the pharmacist's cost of acquiring the drug whole- sale and his cost of dispensing the drug . Now this does not mean that the ...
... reimbursement systems . do not accurately reflect the two components that make up the retail price of a drug - the pharmacist's cost of acquiring the drug whole- sale and his cost of dispensing the drug . Now this does not mean that the ...
Page 11642
... reimbursement rate - fair to the pharmacist , fair to the taxpayer . A reimbursement system must give consideration to the cost of professional services involved in dispensing a drug and a reasonable return to the pharmacist who is , as ...
... reimbursement rate - fair to the pharmacist , fair to the taxpayer . A reimbursement system must give consideration to the cost of professional services involved in dispensing a drug and a reasonable return to the pharmacist who is , as ...
Page 11643
... reimbursement program . Have you given any thought to this kind of a tie - in ? Secretary WEINBERGER . Yes , but we have rejected it , Mr. Gordon , because we do not want to interfere with the basic market system to that extent . We do ...
... reimbursement program . Have you given any thought to this kind of a tie - in ? Secretary WEINBERGER . Yes , but we have rejected it , Mr. Gordon , because we do not want to interfere with the basic market system to that extent . We do ...
Other editions - View all
Common terms and phrases
actual acquisition cost agencies antisubstitution laws APhA average wholesale price bioavailability bioequivalence brand name central CHAIRMAN competitive Defense develop Digoxin dispensing Drug Administration drug product Drug Research Board effective erythromycin established Food and Drug formulary Gaylord Nelson GORDON Government Government-wide hospital implementation inspection Interagency Labs local purchases MAC price MAC program MAC regulations Manufacturing Practices Maximum Allowable Cost Medicaid MEDICAL AND NONPERISHABLE medical items Medicare meeting ment MICHELOTTI patient percent Pharmaceutical pharmacists pharmacy physician PITTMAN prednisone prescribed present problems procurement professional proposed regulations purchasing quality assurance quality assurance program recommendations reimbursement resolution responsibility savings SCHMIDT Secretary WEINBERGER selection Small Business Sorett specific standards statement STETLER subcommittee substitution laws Supply Management Committee Tablets task group therapeutic equivalence tion TRYGSTAD WHITWORTH
Popular passages
Page 12087 - Since many agencies, including the Food and Drug Administration in the Department of Health, Education and Welfare, in which the appellant was employed, have nothing to do with national security, the Act of 1950 has nothing to do with them. The authorization to bring "other...
Page 12159 - Register, to be In the public interest in connection with the performance of duties imposed on that agency by law.
Page 11700 - I AM PLEASED TO BE HERE TODAY AND TO HAVE THE OPPORTUNITY TO ASK QUESTIONS OF SECRETARY JACKSON.
Page 12328 - Engineering before the Subcommittee on Health of the Senate Committee on Labor and Public Welfare, 94th Cong., 1st Sess.
Page 12055 - The hearing need not be conducted according to technical rules relating to evidence and witnesses. Any relevant evidence shall be admitted if it is the sort of evidence on which responsible persons are accustomed to rely in the conduct of serious affairs, regardless of the existence of any common law or statutory rule which might make improper the admission of such evidence over objection in civil actions.
Page 11663 - OF THE SELECT COMMITTEE ON SMALL BUSINESS, Washington, DC The subcommittee met, pursuant to notice, at 10 am, in room 2221.
Page 11925 - Action is pleased to have the opportunity to present its views on the $12.7 billion supplemental appropriation for America's efforts in Vietnam.
Page 11732 - STATEMENT OF ALEXANDER M. SCHMIDT, MD, COMMISSIONER, FOOD AND DRUG ADMINISTRATION; ACCOMPANIED BY J. RICHARD GROUT, MD, DIRECTOR, BUREAU OF DRUGS; PETER BARTON »HUTT, ASSISTANT GENERAL COUNSEL; LLOYD B. TEPPER, MD, ASSOCIATE COMMISSIONER FOR SCIENCE; BARRETT SCOVILLE, MD, ACTING DIRECTOR OF THE DIVISION OF BUREAU OF NEUROt PHARMACOLOGICAL PROJECTS; AND ROBERT WETHERELL, DIRECTOR, OFFICE OF LEGISLATIVE SERVICES Dr.
Page 12055 - substantial evidence" means : Evidence consisting of adequate and well controlled investigations, including clinical investigations by experts qualified by scientific training and experience to evaluate the effectiveness of the drug involved, on the basis of which it could fairly and responsibly be concluded by such experts that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling...
Page 12054 - The means employed shall be such as to allow, to the extent practicable, eligible persons to secure health care in the same manner employed by the public generally, and without discrimination or segregation based purely on their economic disability.